Home Actio Biosciences

Actio Biosciences

acquired
Series B
Precision Medicine Technology Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Actio Biosciences is leveraging advances in precision medicine to develop new therapies targeting shared genes in rare and common diseases, transforming a single meaningful drug into multiple ones. Actio Biosciences applies its expertise in genetics, drug discovery, and data science to identify programs that minimize biological and technical risks, streamline the drug development process, and create highly effective, precisely targeted treatments.
Actio Biosciences, Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2021
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Biotechnology
Concept
Rare Diseases Therapeutic Products
Application Scenarios
Precision Medicine Chemical Drug Innovative Drugs